Surgery Websites
Surgical Oncology Program »  Meet the Team »  Surgical Oncology »  Guilin Qiao, PhD
Guilin Qiao, PhD

Guilin Qiao, PhD

  • Associate Professor of Surgery
  • Division of Surgical Oncology

Contact Information

513 Parnassus Avenue, HSW, #1698
San Francisco, CA 94143
guilin.qiao@ucsf.edu
Open Popup
MOST RECENT PUBLICATIONS FROM A TOTAL OF 8
Data provided by UCSF Profiles, powered by CTSI
  1. Wiley MB, Bauer J, Mehrotra K, Zessner-Spitzenberg J, Kolics Z, Cheng W, Castellanos K, Nash MG, Gui X, Kone L, Maker AV, Qiao G, Reddi D, Church DN, Kerr RS, Kerr DJ, Grippo PJ, Jung B. Non-Canonical Activin A Signaling Stimulates Context-Dependent and Cellular-Specific Outcomes in CRC to Promote Tumor Cell Migration and Immune Tolerance. Cancers (Basel). 2023 May 31; 15(11). View in PubMed
  2. Qiao G, Kone LB, Phillips EH, Lee SS, Brown GE, Khetani SR, Thakur A, Lum LG, Prabhakar BS, Maker AV. LIGHT enhanced bispecific antibody armed T-cells to treat immunotherapy resistant colon cancer. Oncogene. 2022 04; 41(14):2054-2068. View in PubMed
  3. Fernandez MF, Qiao G, Tulla K, Prabhakar BS, Maker AV. Combination Immunotherapy With LIGHT and Interleukin-2 Increases CD8 Central Memory T-Cells In Vivo. J Surg Res. 2021 07; 263:44-52. View in PubMed
  4. Saini S, Sripada L, Tulla K, Qiao G, Kunda N, Maker AV, Prabhakar BS. MADD silencing enhances anti-tumor activity of TRAIL in anaplastic thyroid cancer. Endocr Relat Cancer. 2019 06 01; 26(6):551-563. View in PubMed
  5. Qin J, Kunda NM, Qiao G, Tulla K, Prabhakar BS, Maker AV. Vaccination With Mitoxantrone-Treated Primary Colon Cancer Cells Enhances Tumor-Infiltrating Lymphocytes and Clinical Responses in Colorectal Liver Metastases. J Surg Res. 2019 01; 233:57-64. View in PubMed
  6. View All Publications

 

Site Directory
    X